Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
gilead sciences
5
×
immunotherapy
5
×
indiana blog main
indiana top stories
life sciences
national
5
×
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
gene therapy
cancer immunotherapy
clinical trials
drug prices
glaxosmithkline
medicare
pfizer
alzheimer's disease
amgen
What
bio
roundup
annual
days
drug
price
abbvie’s
acquisitions
ahead
airport
albert
american
apocalypse
approval
ash
beds
biggest
biofourmis
biogen’s
biopharmaceutical
blood
borne
bourla
bucks
cancer
cancers
celebrate
celgene
ceo
chance
companies
company
conference
convo
corner
crispr
day
diego
earlier
failures
Language
unknown
unset
Current search:
immunotherapy
×
national
×
" gilead sciences "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More